Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

Affiliations

• ¹ Dana-Farber Cancer Institute, Boston, MA, USA.
• ² Broad Institute of Harvard and MIT, Cambridge, MA, USA.
• ³ Department of Dermatology, University Hospital Würzburg, Würzburg, Germany.
• ⁴ Department of Dermatology, University Hospital, Essen, Germany.
• ⁵ German Cancer Consortium of Translational Cancer Research, German Cancer Research Center, Heidelberg, Germany.
• ⁶ Harvard Medical School, Boston, MA, USA.
• ⁷ Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
• ⁸ Department of Dermatology, University Medical Center, Mainz, Germany.
• ⁹ Biophysics Program, Harvard University, Cambridge, MA, USA.
• ¹⁰ First Department of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
• ¹¹ Department of Dermatology, University Hospital Zürich, Zürich, Switzerland.
• ¹² Department of Dermatology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
• ¹³ Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany.
• ¹⁴ Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
• ¹⁵ Skin Cancer Center at the University Cancer Centre, Department of Dermatology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
• ¹⁶ National Center for Tumor Diseases, Dresden, Germany.
• ¹⁷ German Cancer Research Centre, Heidelberg, Germany.
• ¹⁸ Department of Dermatology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
• ¹⁹ Medizinische Klinik III, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.
• ²⁰ Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany.
• ²¹ Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
• ²² Department of Dermatology, University Hospital Berlin, Berlin, Germany.
• ²³ Eli Lilly and Co., Indianapolis, IN, USA.
• ²⁴ Massachusetts General Hospital, Boston, MA, USA.
• ²⁵ Dana-Farber Cancer Institute, Boston, MA, USA. [email protected].
• ²⁶ Broad Institute of Harvard and MIT, Cambridge, MA, USA. [email protected].
• ²⁷ Department of Dermatology, University Hospital, Essen, Germany. [email protected].
• ²⁸ German Cancer Consortium of Translational Cancer Research, German Cancer Research Center, Heidelberg, Germany. [email protected].